An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis

Chemistry & Biology
Gladys P De LeonGerard D Wright

Abstract

The lipopolysaccharide (LPS)-rich outer membrane of gram-negative bacteria provides a protective barrier that insulates these organisms from the action of numerous antibiotics. Breach of the LPS layer can therefore provide access to the cell interior to otherwise impermeant toxic molecules and can expose vulnerable binding sites for immune system components such as complement. Inhibition of LPS biosynthesis, leading to a truncated LPS molecule, is an alternative strategy for antibacterial drug development in which this vital cellular structure is weakened. A significant challenge for in vitro screens of small molecules for inhibition of LPS biosynthesis is the difficulty in accessing the complex carbohydrate substrates. We have optimized an assay of the enzymes required for LPS heptose biosynthesis that simultaneously surveys five enzyme activities by using commercially available substrates and report its use in a small-molecule screen that identifies an inhibitor of heptose synthesis.

References

Nov 8, 1996·Science·H R OnishiC R Raetz
Jun 11, 1999·Analytical Biochemistry·E B CoganO H Griffith
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Sep 29, 2004·Current Opinion in Microbiology·Fiona M Walsh, Sebastian G B Amyes
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Jul 21, 2005·Journal of Bacteriology·Koji HiratsukaEleonora Altman

❮ Previous
Next ❯

Citations

Jan 15, 2014·Bioorganic & Medicinal Chemistry·Tiehai LiPeng George Wang
Feb 24, 2011·Expert Reviews in Molecular Medicine·Lindsay Kalan, Gerard D Wright
Apr 8, 2009·Antimicrobial Agents and Chemotherapy·Mark P PereiraEric D Brown
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Jul 21, 2010·Infection and Immunity·Slade A Loutet, Miguel A Valvano
Aug 4, 2011·Frontiers in Microbiology·Slade A Loutet, Miguel A Valvano
Mar 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jenny Fernebro
Dec 22, 2015·Chemistry & Biology·Mirella VivoliNicholas J Harmer
Jul 22, 2008·Current Opinion in Chemical Biology·Sonia Escaich
May 12, 2007·Trends in Molecular Medicine·Gerard D Wright, Arlene D Sutherland
Nov 21, 2013·The Lancet Infectious Diseases·Ramanan LaxminarayanOtto Cars
Jul 19, 2015·International Journal of Antimicrobial Agents·Slade A LoutetMiguel A Valvano
Dec 17, 2009·Structure·Mariya MorarGerard D Wright
Jan 7, 2009·Bioorganic & Medicinal Chemistry·Nicolas DesroySonia Escaich
Dec 1, 2017·Scientific Reports·Mirella VivoliNicholas J Harmer
Nov 14, 2008·Animal Health Research Reviews·Patricia L Taylor, Gerard D Wright
Aug 20, 2010·Expert Opinion on Therapeutic Patents·Sonia Escaich
Feb 27, 2018·PLoS Pathogens·Paul A BeareRobert A Heinzen
Feb 16, 2013·Journal of Medicinal Chemistry·Nicolas DesroyVincent Gerusz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.